These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34222496)

  • 21. Nontypeable Haemophilus influenzae as a pathogen in children.
    Murphy TF; Faden H; Bakaletz LO; Kyd JM; Forsgren A; Campos J; Virji M; Pelton SI
    Pediatr Infect Dis J; 2009 Jan; 28(1):43-8. PubMed ID: 19057458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I, randomized, observer-blind, placebo-controlled studies to evaluate the safety, reactogenicity and immunogenicity of an investigational non-typeable Haemophilus influenzae (NTHi) protein vaccine in adults.
    Leroux-Roels G; Van Damme P; Haazen W; Shakib S; Caubet M; Aris E; Devaster JM; Peeters M
    Vaccine; 2016 Jun; 34(27):3156-3163. PubMed ID: 27133877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of Haemophilus influenzae in the Republic of Ireland, 2010-2018.
    McElligott M; Meyler K; Bennett D; Mulhall R; Drew RJ; Cunney R
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2335-2344. PubMed ID: 32666480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A bacterial vaccine polypeptide protective against nontypable Haemophilus influenzae.
    Whitby PW; Morton DJ; Mussa HJ; Mirea L; Stull TL
    Vaccine; 2020 Mar; 38(14):2960-2970. PubMed ID: 32111525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant C-terminal 311 amino acids of HapS adhesin as a vaccine candidate for nontypeable Haemophilus influenzae: A study on immunoreactivity in Balb/C mouse.
    Tabatabaee Bafroee AS; Siadat SD; Mousavi SF; Aghasadeghi MR; Khorsand H; Nejati M; Sadat SM; Mahdavi M
    Microb Pathog; 2016 Sep; 98():106-11. PubMed ID: 27377430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiological analysis and rapid detection by one-step multiplex PCR assay of Haemophilus influenzae in children with respiratory tract infections in Zhejiang Province, China.
    Fan X; Liu X; Ji L; Cai D; Jiang J; Zhu J; Sun A; Yan J
    BMC Infect Dis; 2018 Aug; 18(1):414. PubMed ID: 30134854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction of recombinant S-layer proteins (rSbsA) and their expression in bacterial ghosts--a delivery system for the nontypeable Haemophilus influenzae antigen Omp26.
    Riedmann EM; Kyd JM; Smith AM; Gomez-Gallego S; Jalava K; Cripps AW; Lubitz W
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):185-92. PubMed ID: 12832124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing trend in invasive non-typeable Haemophilus influenzae disease and molecular characterization of the isolates, Italy, 2012-2016.
    Giufrè M; Fabiani M; Cardines R; Riccardo F; Caporali MG; D'Ancona F; Pezzotti P; Cerquetti M
    Vaccine; 2018 Oct; 36(45):6615-6622. PubMed ID: 30292458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Host-pathogen interactions of nontypeable Haemophilus influenzae: from commensal to pathogen.
    Duell BL; Su YC; Riesbeck K
    FEBS Lett; 2016 Nov; 590(21):3840-3853. PubMed ID: 27508518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PHiD-CV induces anti-Protein D antibodies but does not augment pulmonary clearance of nontypeable Haemophilus influenzae in mice.
    Siggins MK; Gill SK; Langford PR; Li Y; Ladhani SN; Tregoning JS
    Vaccine; 2015 Sep; 33(38):4954-61. PubMed ID: 26212006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of a peroxiredoxin-glutaredoxin by Haemophilus influenzae in biofilms and during human respiratory tract infection.
    Murphy TF; Kirkham C; Sethi S; Lesse AJ
    FEMS Immunol Med Microbiol; 2005 Apr; 44(1):81-9. PubMed ID: 15780580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae.
    Finney LJ; Ritchie A; Pollard E; Johnston SL; Mallia P
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1119-32. PubMed ID: 25342897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nontypeable Haemophilus influenzae (NTHi).
    Bakaletz LO; Novotny LA
    Trends Microbiol; 2018 Aug; 26(8):727-728. PubMed ID: 29793827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction and immunogenicity of recombinant adenovirus vaccines expressing the HMW1, HMW2, or Hia adhesion protein of nontypeable Haemophilus influenzae.
    Winter LE; Barenkamp SJ
    Clin Vaccine Immunol; 2010 Oct; 17(10):1567-75. PubMed ID: 20685934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Taiwan.
    Lin TY; Lu CY; Chang LY; Chiu CH; Huang YC; Bock HL; Tang H; François N; Moreira M; Schuerman L; Huang LM
    J Formos Med Assoc; 2012 Sep; 111(9):495-503. PubMed ID: 23021506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of nontypeable Haemophilus influenzae protein E (PE) as a microbial adjuvant on the amount of antibody against PRP of Haemophilus influenzae type b (Hib) in BALB/c mice.
    Tavakoli M; Bouzari S; Jafari A; Oloomi M; Asadi Karam MR; Najar-Peerayeh S; Siadat SD
    Microb Pathog; 2019 Apr; 129():78-81. PubMed ID: 30682526
    [No Abstract]   [Full Text] [Related]  

  • 37. Antibody against Haemophilus influenzae protein D in patients with chronic conditions causing secondary immunodeficiency.
    Hawdon N; Biman B; McCready W; Brigden M; Malik S; Vergidis D; Kisselgoff O; Ulanova M
    Vaccine; 2012 Feb; 30(7):1235-8. PubMed ID: 22230580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemophilus influenzae vaccine candidate outer membrane protein P6 is not conserved in all strains.
    Chang A; Kaur R; Michel LV; Casey JR; Pichichero M
    Hum Vaccin; 2011 Jan; 7(1):102-5. PubMed ID: 21285530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies against the majority subunit of type IV Pili disperse nontypeable Haemophilus influenzae biofilms in a LuxS-dependent manner and confer therapeutic resolution of experimental otitis media.
    Novotny LA; Jurcisek JA; Ward MO; Jordan ZB; Goodman SD; Bakaletz LO
    Mol Microbiol; 2015 Apr; 96(2):276-92. PubMed ID: 25597921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of lipid modification on the physicochemical, structural, antigenic and immunoprotective properties of Haemophilus influenzae outer membrane protein P6.
    Yang YP; Munson RS; Grass S; Chong P; Harkness RE; Gisonni L; James O; Kwok Y; Klein MH
    Vaccine; 1997 Jun; 15(9):976-87. PubMed ID: 9261944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.